FI905356A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten (2S,3S,5R)-2-(3,5-difluorifenyyli)-3,5-dimetyyli-2-morfolinolien ja niiden rasemaattien ja suolojen valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten (2S,3S,5R)-2-(3,5-difluorifenyyli)-3,5-dimetyyli-2-morfolinolien ja niiden rasemaattien ja suolojen valmistamiseksi

Info

Publication number
FI905356A0
FI905356A0 FI905356A FI905356A FI905356A0 FI 905356 A0 FI905356 A0 FI 905356A0 FI 905356 A FI905356 A FI 905356A FI 905356 A FI905356 A FI 905356A FI 905356 A0 FI905356 A0 FI 905356A0
Authority
FI
Finland
Prior art keywords
morpholinols
racemates
salts
difluorophenyl
dimethyl
Prior art date
Application number
FI905356A
Other languages
English (en)
Swedish (sv)
Other versions
FI94753C (fi
FI94753B (fi
Inventor
James Leroy Kelley
David Lee Musso
Grady Evan Boswell
Barrett Randolph Cooper
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI905356A0 publication Critical patent/FI905356A0/fi
Application granted granted Critical
Publication of FI94753B publication Critical patent/FI94753B/fi
Publication of FI94753C publication Critical patent/FI94753C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI905356A 1989-10-31 1990-10-30 Menetelmä uusien terapeuttisesti käyttökelpoisten (2S,3S,5R)-2-(3,5-difluorifenyyli)-3,5-dimetyyli-2-morfolinolien ja niiden rasemaattien ja suolojen valmistamiseksi FI94753C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8924528 1989-10-31
GB898924528A GB8924528D0 (en) 1989-10-31 1989-10-31 Heterocyclic pharmaceutical compounds,preparation and use

Publications (3)

Publication Number Publication Date
FI905356A0 true FI905356A0 (fi) 1990-10-30
FI94753B FI94753B (fi) 1995-07-14
FI94753C FI94753C (fi) 1995-10-25

Family

ID=10665482

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905356A FI94753C (fi) 1989-10-31 1990-10-30 Menetelmä uusien terapeuttisesti käyttökelpoisten (2S,3S,5R)-2-(3,5-difluorifenyyli)-3,5-dimetyyli-2-morfolinolien ja niiden rasemaattien ja suolojen valmistamiseksi

Country Status (19)

Country Link
US (1) US5104870A (fi)
EP (1) EP0426416B1 (fi)
JP (1) JP2873076B2 (fi)
AT (1) ATE101604T1 (fi)
AU (1) AU645763B2 (fi)
CA (1) CA2028893C (fi)
DE (1) DE69006682T2 (fi)
DK (1) DK0426416T3 (fi)
ES (1) ES2062406T3 (fi)
FI (1) FI94753C (fi)
GB (1) GB8924528D0 (fi)
HU (2) HU207304B (fi)
IE (1) IE66115B1 (fi)
LV (1) LV11030B (fi)
MX (1) MX9203219A (fi)
NZ (1) NZ235882A (fi)
PT (1) PT95735B (fi)
SG (1) SG28347G (fi)
ZA (1) ZA908696B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
AU1403899A (en) * 1997-11-14 1999-06-07 Glaxo Group Limited Method of treating addiction to nicotine products
MA26693A1 (fr) * 1998-09-28 2004-12-20 Glaxo Group Ltd Compositions pour administration par voie buccale
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
US7763612B2 (en) * 2006-01-03 2010-07-27 Algebra, Inc. Therapeutic amine-arylsulfonamide conjugate compounds
AU2010236404B2 (en) 2009-04-15 2016-11-03 Research Triangle Institute Monoamine reuptake inhibitors
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
AU2011255456B2 (en) * 2010-05-21 2017-01-19 Dignity Health Doing Business As St. Joseph's Hospital And Medical Center And Barrow Neurological Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds

Also Published As

Publication number Publication date
PT95735B (pt) 1998-01-30
EP0426416A1 (en) 1991-05-08
DE69006682T2 (de) 1994-08-04
DE69006682D1 (de) 1994-03-24
HU906935D0 (en) 1991-05-28
LV11030B (en) 1996-08-20
ATE101604T1 (de) 1994-03-15
ES2062406T3 (es) 1994-12-16
MX9203219A (es) 1992-07-01
LV11030A (lv) 1996-02-20
PT95735A (pt) 1991-09-13
JPH03206084A (ja) 1991-09-09
FI94753C (fi) 1995-10-25
CA2028893A1 (en) 1991-05-01
CA2028893C (en) 2000-10-10
AU6563990A (en) 1991-05-09
AU645763B2 (en) 1994-01-27
SG28347G (en) 1995-09-18
IE66115B1 (en) 1995-12-13
US5104870A (en) 1992-04-14
HU211304A9 (en) 1995-11-28
DK0426416T3 (da) 1994-03-14
JP2873076B2 (ja) 1999-03-24
IE903888A1 (en) 1991-05-08
HU207304B (en) 1993-03-29
NZ235882A (en) 1993-05-26
FI94753B (fi) 1995-07-14
ZA908696B (en) 1992-07-29
GB8924528D0 (en) 1989-12-20
HUT57748A (en) 1991-12-30
EP0426416B1 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
GB8823731D0 (en) Biologically active compounds
HU9301579D0 (en) Compounds having medical effect
EP1473294A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
FI905356A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten (2S,3S,5R)-2-(3,5-difluorifenyyli)-3,5-dimetyyli-2-morfolinolien ja niiden rasemaattien ja suolojen valmistamiseksi
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
KR880007070A (ko) 백내장 치료용 약학 조성물
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
FI860816A (fi) Menetelmä terapeuttisesti käyttökelpoisten polyprenyyliyhdisteiden valmistamiseksi
DE69017839D1 (de) NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
RU94042230A (ru) Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии
DE69113338D1 (de) Pyranobenzoxadiazolderivate.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE WELLCOME FOUNDATION LIMITED

MA Patent expired